Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2026 before the market opens on ...

Labcorp Holdings (NYSE:LH) is expanding its New York footprint through the acquisition of assets and operations from Crouse Health and Lab Alliance. The company is also extending its collaboration ...

Novartis and Labcorp Raritan are soon to lay off dozens of employees as part of a restructuring.

A large regional health system has saved more than $5 million a year on labor and supplies—and even more with capital expense avoidance—by partnering with Labcorp. Within a period of one year, Labcorp ...

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

Labcorp completes Crouse Health lab asset acquisition, taking over 12 patient service centers and inpatient lab operations in ...

Labcorp’s testing capabilities are getting a little broader with the $237.5 million acquisition of certain laboratory assets from BioReference Health, a subsidiary of Opko Health. The BioReference ...

The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...

Shares of Labcorp Holdings Inc. LH rose 1.21% to $266.81 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 2.91% to 6,528.52 ...

This article will take a look at how LabCorp OnDemand’s COVID-19 test works. How does LabCorp OnDemand’s COVID-19 test work? Previously called Pixel by LabCorp, LabCorp OnDemand’s COVID-19 Test uses ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min As the number of Americans at ...

Laboratory Corporation of America will pay the U.S. $2.1 million to settle allegations that it overbilled the Department of Defense for genetic tests that involved children and fetuses, the Department ...